Currently, the mechanism of preparation-specific risks for hypophosphatemia is not fully understood, but the carbohydrate backbones of certain iron formulations, including FCM, may inhibit the cleavage of intact FGF23, leading to renal phosphate loss and hypophosphatemia [25]. This evidence concerns the gene FGF23 and hypophosphatemia.